Home/Filings/4/0001415889-17-000230
4//SEC Filing

MABVAX THERAPEUTICS HOLDINGS, INC. 4

Accession 0001415889-17-000230

CIK 0001109196operating

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 4:03 PM ET

Size

5.4 KB

Accession

0001415889-17-000230

Insider Transaction Report

Form 4
Period: 2017-02-06
Resnick Paul F
Vice President, CBO
Transactions
  • Award

    Option to Purchase Common Stock

    2017-02-06$2.99/sh+35,000$104,65035,000 total
    Exercise: $2.99Exp: 2027-02-06Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]The Option Shares shall vest in three equal annual installments commencing on the first anniversary of the Vesting Commencement Date.

Issuer

MABVAX THERAPEUTICS HOLDINGS, INC.

CIK 0001109196

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001109196

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:03 PM ET
Size
5.4 KB